发明授权
- 专利标题： Pharmaceutical use of N-carbamoylazole derivatives
- 专利标题（中）： N-氨基甲酰唑衍生物的药用
-
申请号： US10766388申请日： 2004-01-27
-
公开(公告)号： US07238720B2公开(公告)日： 2007-07-03
- 发明人: Nobuyuki Yasuda , Tadashi Nagakura , Kazuto Yamazaki , Seiji Yoshikawa , Toshimi Okada , Hironori Ikuta , Mika Koyanagi
- 申请人： Nobuyuki Yasuda , Tadashi Nagakura , Kazuto Yamazaki , Seiji Yoshikawa , Toshimi Okada , Hironori Ikuta , Mika Koyanagi
- 申请人地址： JP Tokyo
- 专利权人： Eisai R & D Management Co. Ltd.
- 当前专利权人： Eisai R & D Management Co. Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Morgan & Finnegan, LLP
- 优先权： JP2001-149983 20010518
- 主分类号： A61K31/4196
- IPC分类号： A61K31/4196 ; A61K31/416 ; C07D43/02
摘要：
The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects. The present invention provides a dipeptidyl peptidase IV inhibiting agent comprising a compound represented by the general formula (I):
公开/授权文献
- US20040186153A1 Pharmaceutical use of N-carbamoylazole derivatives 公开/授权日：2004-09-23